CCL2 and neoplasm: The nonsteroidal anti-inflammatory drug, celecoxib, has shown ability to induce apoptosis of tumor cells by decreasing the expression of CCL2 and CXC motif chemokine ligand 10 (CXCL10), further demonstrating the potential this pathway must influence downstream immunosuppression and tumor cell persistence [37].